Key facts
- This page summarizes Robert A. Eckert's Form 4 filing for AMGEN INC (AMGN).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Aug 2022, 17:38.
Robert A. Eckert - 10 Aug 2022 Form 4 Insider Report for AMGEN INC (AMGN)
- Reporting relationship
- Director
- Issuer ticker
- AMGN
- Reported as of
- 10 Aug 2022
- Net transaction value
- -$143
- SEC form
- 4
- Accepted by SEC
- 12 Aug 2022, 17:38:53 UTC
- Prior SEC filing
- 25 May 2022
- Next SEC filing
- 18 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrea Robinson, Attorney-in-Fact for Mr. Eckert
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert A. Eckert filed Form 4 for AMGEN INC (AMGN) on 12 Aug 2022.
Change
- Previous filing in this sequence was filed on 25 May 2022.
- Current net transaction value: -$143.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMGN
transaction
Common Stock
Options Exercise
- Transaction value
- $1,711,800
- Shares
- +20,000
- Change %
- +137%
- Price
- $85.59
- Shares after
- 34,575
- Date
- 10 Aug 2022
- Ownership
- Direct
AMGN
transaction
Common Stock
Tax liability
- Transaction value
- $1,711,943
- Shares
- -6,791
- Change %
- -20%
- Price
- $252.09
- Shares after
- 27,784
- Date
- 10 Aug 2022
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AMGN
transaction
Derivative
Nqso (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -20,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 10 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $85.59
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Non-market exercise of a total of 20,000 stock options expiring January 28, 2023 wherein 6,791 shares, in the aggregate, issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price with the remaining shares delivered to the reporting person.
Footnote F2
These shares include 2,008 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.